However, recent studies have shown that more than 70% of cancer patients express mesothelin in their tissues, including colorectal cancer, lung cancer, stomach cancer, mesothelioma, ovarian cancer, and pancreatic cancer [10, 11]. Here, MSLN is linked to ovarian cancer.